Caplacizumab: an anti-von Willebrand factor antibody for the treatment of thrombotic thrombocytopenic purpura.
Hollifield, Alyssa L (PharmD student); Arnall, Justin R PharmD, BCOP, CPP; Moore, Donald C PharmD, BCPS, BCOP, DPLA
[Review] American Journal of Health-System Pharmacy.

(Format: HTML, PDF)